Core Viewpoint - Haijia Medical (06078) anticipates a decline in revenue and net profit for 2025, primarily due to goodwill impairment and increased operational costs [1][4] Financial Projections - Expected revenue for 2025 is approximately RMB 4.0–4.5 billion, representing a year-on-year decrease of about 9% to 10% [1][4] - Projected net profit is around RMB 140–200 million, reflecting a year-on-year decline of approximately 66% to 76% [1][4] - Adjusted net profit is estimated to be between RMB 450–490 million, down about 19% to 25% year-on-year [1][4] - Cash generated from operating activities is expected to be around RMB 940–1,000 million, showing an increase of approximately 33% to 41% year-on-year [1][4] Factors Influencing Financial Performance - The decline in revenue, net profit, and adjusted net profit is attributed to industry and macroeconomic impacts, as well as increased startup costs and depreciation for newly opened hospitals [1][4] - The net profit decrease is also significantly influenced by the goodwill impairment provision related to Etern Group Ltd. [1][4] - The company has conducted a careful assessment of its operational and financial performance, as well as future business prospects, to determine the necessity and amount of the impairment and provision [1][4]
海吉亚医疗午后涨超3% 预计去年收入净利下跌经营性现金流增超33%